Covid-19 prevalence, disease course, and impact on pulmonary outcome in a TB cohort in four African countries (Covid-19_TB)

  • Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Total publications:0 publications

Grant number: 01KI20390

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $57,564
  • Funder

    Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Principle Investigator

    Pending
  • Research Location

    Germany, Europe
  • Lead Research Institution

    Ludwig-Maximilians-Universität München
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Other

  • Occupations of Interest

    Unspecified

Abstract

The aim of the project is to examine the effects of Covid 19 disease on tuberculosis patients in four African countries (Gambia, Mozambique, South Africa and Tanzania). For this purpose, appropriate clinical data are collected and analyzed on site. The frequency of the diseases and other epidemiological parameters of the SARS-CoV-2 infection as well as the clinical characteristics of the Covid-19 disease are to be described and compared with other patient groups and the healthy population. In addition, the interrelationship between pulmonary tuberculosis (and chronic lung disease after TB) and Covid-19 in terms of the severity and severity of both diseases is the subject of the project. The work is flanked by questions relating to social science aspects.